GENFIT Announces Publication in Nature Medicine Confirming

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); September 26, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage...

Related Keywords

France ,Paris ,France General ,Cambridge ,Cambridgeshire ,United Kingdom ,Canada ,United States ,Switzerland ,Massachusetts ,Arunj Sanyal ,Stravitz Sanyal Institute For Liver Disease ,Laboratory Developed Test ,Drug Administration ,European Medicines Agency ,Nasdaq ,Uncertainties Of The Company ,National Institutes Of Health ,Exchange Commission ,Foundation For The National Institutes Of Health ,Euronext ,Biomarkers Consortium ,Non Invasive Tests ,Nature Medicine ,Stravitz Sanyal Institute ,Liver Disease ,Laboratory Developed ,National Institutes ,European Medicines ,Primary Biliary Cholangitis ,Nasdaq Global Select Market ,Private Securities Litigation Reform Act ,Registration Document ,Half Year Business ,Financial Report ,Paris Stock Exchange Gnft ,Genfit Sa ,